Your browser doesn't support javascript.
loading
Chronodisruption and diet associated with increased cardiometabolic risk in coronary heart disease patients: the CORDIOPREV study.
Romero-Cabrera, Juan Luis; Garaulet, Marta; Jimenez-Torres, Jose; Alcala-Diaz, Juan F; Quintana Navarro, Gracia M; Martin-Piedra, Laura; Torres-Peña, Jose David; Rodriguez-Cantalejo, Fernando; Rangel-Zuñiga, Oriol Alberto; Yubero-Serrano, Elena Maria; Luque, Raul M; Ordovas, Jose M; Lopez-Miranda, Jose; Pérez-Martínez, Pablo; García-Rios, Antonio.
Afiliación
  • Romero-Cabrera JL; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Garaulet M; Department of Physiology, University of Murcia, Murcia, Spain; Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, and Division of Sleep Medicine, Harvard Medical School, Boston, Massachusetts.
  • Jimenez-Torres J; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Alcala-Diaz JF; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Quintana Navarro GM; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Martin-Piedra L; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Torres-Peña JD; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Rodriguez-Cantalejo F; Biochemical Laboratory, Reina Sofia University Hospital, Córdoba, Spain.
  • Rangel-Zuñiga OA; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Yubero-Serrano EM; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Luque RM; Department of Cell Biology, Physiology and Immunology, Maimonides Biomedical Research Institute of Cordoba (IMIBIC); University of Cordoba; CIBER Physiopathology of Obesity and Nutrition (CIBERobn), Reina Sofia University Hospital (HURS), Córdoba, Spain.
  • Ordovas JM; Nutrition and Genomics Laboratory, J.M, US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts; IMDEA Food Institute, Madrid, Spain.
  • Lopez-Miranda J; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • Pérez-Martínez P; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain.
  • García-Rios A; Lipids and Atherosclerosis Unit, Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Córdoba, Spain; CIBEROBN (CIBER in Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, Madrid, Spain. Electronic address: a
Transl Res ; 242: 79-92, 2022 04.
Article en En | MEDLINE | ID: mdl-34752950
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Enfermedad Coronaria / Síndrome Metabólico Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transl Res Asunto de la revista: MEDICINA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Enfermedad Coronaria / Síndrome Metabólico Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Transl Res Asunto de la revista: MEDICINA / TECNICAS E PROCEDIMENTOS DE LABORATORIO Año: 2022 Tipo del documento: Article País de afiliación: España Pais de publicación: Estados Unidos